Related Experiment Videos
Calciphylaxis: case report and literature review.
A O Somorin1, A Al Harbi, Y Subaity
1Department of Medicine, North West Armed Forces Hospital, PO Box 100, Tabuk, KSA.
African Journal of Medicine and Medical Sciences
|January 10, 2003
Summary
Calciphylaxis, a rare but severe condition causing painful skin calcification, can affect patients with end-stage renal disease and hyperparathyroidism. Early recognition by multiple specialists is crucial for managing this life-threatening disease.
Area of Science:
- Nephrology
- Dermatology
- Metabolic Diseases
Background:
- Tissue calcification is common, but calciphylaxis is a rare, enigmatic condition.
- Calciphylaxis can be experimentally induced or occur naturally in human diseases.
- Patients with end-stage renal disease (ESRD) and hyperparathyroidism (HPT) are at increased risk, but it can also affect non-renal patients.
Observation:
- A case of sudden, excruciatingly painful cutaneous calciphylaxis in a Saudi Arabian tertiary medical center patient is reported.
- The patient required an acute dermatology emergency consultation.
- This case occurred within a large patient cohort including hemodialysis, dermatology, and general medical patients.
Findings:
- Calciphylaxis is a rare, life-threatening disease.
- Despite risk factors like ESRD and HPT, not all at-risk patients develop calciphylaxis.
- The condition necessitates a high index of suspicion among various medical specialists.
Implications:
- Early and accurate diagnosis of calciphylaxis is critical.
- Multidisciplinary collaboration among dermatologists, general physicians, nephrologists, and pulmonologists is essential.
- Implementing total quality management strategies is advised for this rare, severe condition.